Nucleus Biologics
PrivateMomentum
Top 25%
of companies Caplight tracks
Company Overview
Nucleus Biologics operates in Healthcare & Life Sciences and is based in San Diego, California. It was founded in 2016.
Nucleus Biologics is a biotechnology company that provides custom cell culture media, buffers, and reagents for the cell and gene therapy industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nucleus Biologics Comparables
Compare Nucleus Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gemini Bioproducts, LLC | 85% | |
| Ampersand Capital Partners | 81% | |
| RoosterBio | 78% |
For institutional investors. Book with your work email.
Nucleus Biologics Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 129% MoM, reaching 5.7K.
- Dec 9, 2025
Monthly visitors grew 31% MoM, reaching 3.4K.
For institutional investors. Book with your work email.
Nucleus Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nucleus Biologics's valuation, stock price, and market status.
Is Nucleus Biologics a public or private company?
Nucleus Biologics is a private company.
What is the current stock price of Nucleus Biologics?
Nucleus Biologics is a private company, so its shares have no public market price. Caplight tracks Nucleus Biologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nucleus Biologics worth (valuation)?
Valuation information for Nucleus Biologics is not publicly available.
Can I buy Nucleus Biologics stock?
Nucleus Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nucleus Biologics's last funding round?
Funding round information for Nucleus Biologics is not publicly available.
Who are the main investors in Nucleus Biologics?
Investor information for Nucleus Biologics is not publicly disclosed.
Will Nucleus Biologics IPO soon?
No public IPO plans have been announced for Nucleus Biologics.
How can I track Nucleus Biologics secondary market activity?
Caplight tracks bids, offers, and trades in Nucleus Biologics's shares on secondary markets.